Renovia Ace 10 mg/10 mg film - coated tablets Bulgaria - bulgaro - Изпълнителна агенция по лекарствата

renovia ace 10 mg/10 mg film - coated tablets

recordati ireland limited - Лерканидипин хидрохлорид, Эналаприла малеат - 10 mg/10 mg film - coated tablets

Renovia Ace 20 mg/10 mg film - coated tablets Bulgaria - bulgaro - Изпълнителна агенция по лекарствата

renovia ace 20 mg/10 mg film - coated tablets

recordati ireland limited - Лерканидипин хидрохлорид, Эналаприла малеат - 20 mg/10 mg film - coated tablets

Viacoram 3,5 mg/2,5 mg tablets Bulgaria - bulgaro - Изпълнителна агенция по лекарствата

viacoram 3,5 mg/2,5 mg tablets

les laboratoires servier - besilate амлодипина, Периндоприла аргинин - 3,5 mg/2,5 mg tablets

Viacoram 7 mg/5 mg tablets Bulgaria - bulgaro - Изпълнителна агенция по лекарствата

viacoram 7 mg/5 mg tablets

les laboratoires servier - besilate амлодипина, Периндоприла аргинин - 7 mg/5 mg tablets

Renovia Ace 20 mg/20 mg film - coated tablets Bulgaria - bulgaro - Изпълнителна агенция по лекарствата

renovia ace 20 mg/20 mg film - coated tablets

recordati ireland limited - Лерканидипин хидрохлорид, Эналаприла малеат - 20 mg/20 mg film - coated tablets

Renovia 10 mg film - coated tablets Bulgaria - bulgaro - Изпълнителна агенция по лекарствата

renovia 10 mg film - coated tablets

berlin-chemie ag (menarini group) - Лерканидипин - 10 mg film - coated tablets

Renovia 20 mg film - coated tablets Bulgaria - bulgaro - Изпълнителна агенция по лекарствата

renovia 20 mg film - coated tablets

berlin-chemie ag (menarini group) - Лерканидипин - 20 mg film - coated tablets

Rivaroxaban Viatris (previously Rivaroxaban Mylan) Unione Europea - bulgaro - EMA (European Medicines Agency)

rivaroxaban viatris (previously rivaroxaban mylan)

mylan ireland limited - ривароксабан - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - Антитромботични агенти - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

BROVARABIES V-RG Bulgaria - bulgaro - БАБХ (Българска агенция по безопасност на храните)

brovarabies v-rg

САМ - БС ЕООД - Антиген Р-ТНА - блистер с антиген включен в ядлива примамка - 10 на 8 степен tcid50 - диви животни

Zyclara Unione Europea - bulgaro - EMA (European Medicines Agency)

zyclara

viatris healthcare limited - имиквимод - keratosis; keratosis, actinic - Антибиотици и химиотерапевтици за дерматологично приложение - zyclara е показан за локално лечение на клинично типични, non хиперкератотични, -Хипертрофична, видими или осезаеми актинични кератоза на Анфас или оплешивяване скалпа при имунокомпетентни възрастни, когато други възможности за локално лечение са противопоказан или по-малко подходящи.